Kite Pharma is working on a treatment which involves taking a cancer patient's own t-cells out of their body, genetically modifying them to better target cancer, and then re-administering them. Its CEO Arie Belldegrun, provides insight to the positive study with the therapy.» Read More
CNBC's Meg Tirrell reports on a new scientific discovery for the more than $1.7 billion U.S. business of in vitro fertilization. Robert Frank provides insight.
Google Glass might have another purpose than just entertaining. Dr Horng from Boston said that it helped saved a patient's life last January.
CNBC contributor Barbara Ryan provides insight into new guidelines from the World Health Organization, which strongly endorses two new hepatitis c drugs.
The scientific effort to inform the public about landslide risks often run head-on into powerful economic interests.
On Autism Awareness Day, Pulitzer Prize-winning journalist and author Ron Suskind shared what he's learned from dealing with his youngest son's struggles with the condition.
The FTC has sued pharmaceutical companies $1 billion for delaying the sale of cheaper medicines after patents on brand-name drugs may have expired.
*But costs high, at $60- $250 a tonne of carbon dioxide-IPCC. OSLO, March 26- A little-known technology that may be able to take the equivalent of China's greenhouse gas emissions out of the carbon cycle could be the radical policy shift needed to slow climate change this century, a draft U.N. report shows.
LONDON, March 25- Air pollution killed about 7 million people in 2012, making it the world's single biggest environmental health risk, the World Health Organisation said on Tuesday.
CNBC's Sue Herera speaks with teen inventor Ann Makosinski who took top honors in the Google Science fair for her battery free flashlight, powered by the heat of a person's hand.
CNBC's Sheila Dharmarajan reports 15 percent of high school aged children are diagnosed with ADHD, or attention deficit hyperactivity disorder.
Dr. Richard Saul wrote a book called "ADHD Does Not Exist." Saul is certain attention ADHD, or attention deficit hyperactivity disorder exists only in its symptoms. The condition does not exist.
Data from the small study of the Sangamo BioSciences therapy, known by the code name SB-728-T, were issued in the New England Journal of Medicine, the first publication of data from a human trial of a technology called "gene editing." The Phase 1 trial, led by the University of Pennsylvania, enrolled 12 HIV patients.
Sam Isaly of OrbiMed Advisors, explains why he likes the new products of Regeneron, and why he expects Intermune to go higher.
WASHINGTON, March 3- As the years-long fight over the Keystone XL pipeline grinds toward resolution, green groups are broadening their focus to include the possibility that the Obama administration will loosen curbs on how much oil and gas the United States exports.
If you've been wanting to abandon your cubicle to get your own office, there are good scientific excuses that may convince your boss.
Scientists are working to ensure astronauts don't die of dehydration. Now those solutions could ease futures droughts on earth.
Scientists have found a way to reprogram mature animal cells back into an embryonic-like state that allows them to generate many types of tissue.
Neurocrine Biosciences' president and CEO Kevin Gorman, Ph. D., provides insight on clinical trials for its tardive dyskinesia treatment.
The U.S. remains woefully underprepared for future polar vortexes, Bill Nye, "The Science Guy," told CNBC on Tuesday.
Bill Nye, The Planetary Society executive director, discusses the dangerous conditions of the "polar vortex" and the risk extremely cold weather poses to machines and our own bodies.